# Rotation Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rotation-medical

- Industry: Medical Devices & Equipment
- Headquarters: Plymouth, US
- Website: www.rotationmedical.com
- Total disclosed funding: $52M
- Latest round: Series B (Jul 28, 2016)
- Investors on record: 4

## About

Rotation Medical, Inc. specializes in providing advanced solutions for orthopedic surgeries. The company is known for its innovative approach to enhancing medical outcomes through technology and patient care.Founded in 2009, Rotation Medical, Inc. operates in Plymouth, US, focusing on the development of orthopedic products. In October 2017, the company was acquired by Smith & Nephew plc for USD 125 mn, with potential additional payments of USD 85 mn contingent on financial milestones.Currently, the company's website indicates that it is for sale, and specific details regarding its main products or services are not available. However, if operational, Rotation Medical likely provided medical resources and information aimed at improving health outcomes for healthcare professionals and institutions. Potential customer segments included hospitals, clinics, and individual healthcare providers across North America, Europe, and Asia.As the company is listed for sale, specific revenue information is unavailable. Typically, a medical resource company like Rotation Medical would generate revenue through various channels such as B2B partnerships with healthcare providers or direct-to-consumer sales. Revenue models could include subscription fees for proprietary databases, licensing fees for software, or sales of medical products, although specific financial details remain undetermined.Following its acquisition by Smith & Nephew plc in October 2017, which is expected to close in the fourth quarter of 2017, Rotation Medical will likely leverage the funding from the transaction of USD 125 mn and potential additional payments of USD 85 mn to enhance its product offerings and expand into new markets. Specific future products or geographical regions targeted for expansion have not been disclosed.

## Funding rounds

- Series B, Jul 28, 2016, $8M — New Enterprise Associates, EQT Life Sciences, Pappas Capital
- Series B, Jul 1, 2014, $27M — New Enterprise Associates, EQT Life Sciences, Pappas Capital
- Series A, Apr 13, 2011, $10M — New Enterprise Associates
- Series A, Apr 13, 2010, $3.9M — New Enterprise Associates, Thomas, McNerney & Partners
- Series A, Jan 2, 2007, $3M — New Enterprise Associates

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A, Series B
- Thomas, McNerney & Partners (https://capitalatlas.ai/funds/thomas-mcnerney-partners) — Series A
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series B
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series B